跳至主要内容
临床试验/CTRI/2022/09/045180
CTRI/2022/09/045180招募中3 期

Efficacy of Epinephrine versus Nor-epinephrine as the initial vasoactive agent in Paediatric hematoncology patients with shock- A Feasibility Pilot study - NEO study

Apollo Hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Hematoncology patients aged 1 month to 17 years with early shock, defined as children with unresolved shock/hypoperfusion after the initial 10- 20ml/kg fluid bolus.

排除标准

  • 1.Children with fulminant myocarditis
  • 2.Children with established, untreated heart disease
  • 3.Parents not willing to participate in the study
  • 4.Caregiver/Physician unwilling for patient to be enrolled
  • 5.Post-arrest shock
  • 6.Moribund patients in whom anticipated survival < 24 hrs (since many are in recalcitrant downward spiral of overall condition where the impact of one or other vasoactive may be difficult to assess).

研究者

相似试验

Comparison between adrenaline vs noradrenaline in... | 临床试验